ESSA Pharma Inc.
EPIX
$0.2456
-$0.0175-6.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.69% | -2.75% | -20.56% | -7.37% | -0.89% |
| Total Depreciation and Amortization | -8.94% | -9.63% | -17.93% | -23.40% | -21.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.19% | 175.67% | 168.31% | 41.71% | -21.49% |
| Change in Net Operating Assets | -147.97% | -233.71% | -41.06% | -117.90% | 42.53% |
| Cash from Operations | 12.39% | 2.47% | -0.94% | -14.83% | -4.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -70.52% | -75.62% | 1,184.41% | 2,702.40% | 1,166.50% |
| Cash from Investing | -70.52% | -75.62% | 1,184.41% | 2,702.40% | 1,166.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 76.96% |
| Issuance of Common Stock | -93.25% | -90.07% | 238.87% | 1,247.31% | 1,658.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -93.00% | -89.22% | 545.04% | 1,461.18% | 1,057.64% |
| Foreign Exchange rate Adjustments | 54.76% | -2.13% | 171.88% | 279.17% | -93.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.07% | -111.34% | 465.12% | 399.50% | 261.62% |